Literature DB >> 22270077

Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria.

John McBeth1, Matthew R Mulvey.   

Abstract

Fibromyalgia is a disorder characterized by chronic widespread pain in the presence of widespread tenderness, and multiple somatic symptoms. Since the publication of the American College of Rheumatology (ACR) 1990 classification criteria for fibromyalgia, research has proliferated and, in a relatively short period, investigators have begun to unravel the etiology and long-term impact of this complex condition. Although the ACR 1990 criteria have been central to fibromyalgia research during the past two decades, a number of practical and philosophical objections have been raised in relation to them. Principally these objections have centered on the use (or lack thereof) of the tender point examination, the lack of consideration of associated symptoms, and the observation that fibromyalgia might represent the extreme end of a pain continuum. In developing the ACR 2010 criteria, experts have sought to address these issues and to simplify clinical diagnosis. An implicit aim was to facilitate more rigorous study of etiology. The purpose of this Review is to summarize research to date that has described the epidemiology, pathology and clinical course of fibromyalgia, and to assess the probable impact of the ACR 2010 criteria on future research efforts.

Entities:  

Mesh:

Year:  2012        PMID: 22270077     DOI: 10.1038/nrrheum.2011.216

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  125 in total

1.  The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario.

Authors:  K P White; M Speechley; M Harth; T Ostbye
Journal:  J Rheumatol       Date:  1999-07       Impact factor: 4.666

2.  Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample.

Authors:  Kevin P White; Warren R Nielson; Manfred Harth; Truls Ostbye; Mark Speechley
Journal:  J Rheumatol       Date:  2002-03       Impact factor: 4.666

3.  The burden of musculoskeletal diseases in the general population of Spain: results from a national survey.

Authors:  L Carmona; J Ballina; R Gabriel; A Laffon
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

4.  Prevalence of primary and secondary fibrositis.

Authors:  F Wolfe; M A Cathey
Journal:  J Rheumatol       Date:  1983-12       Impact factor: 4.666

5.  Assessment of nonarticular tenderness and prevalence of fibromyalgia in children.

Authors:  D Buskila; J Press; A Gedalia; M Klein; L Neumann; R Boehm; S Sukenik
Journal:  J Rheumatol       Date:  1993-02       Impact factor: 4.666

6.  The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.

Authors:  Philip J Mease; Daniel J Clauw; R Michael Gendreau; Srinivas G Rao; Jay Kranzler; Wei Chen; Robert H Palmer
Journal:  J Rheumatol       Date:  2009-02       Impact factor: 4.666

7.  A prospective long-term study of fibromyalgia syndrome.

Authors:  M Kennedy; D T Felson
Journal:  Arthritis Rheum       Date:  1996-04

Review 8.  Pathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition.

Authors:  Lars Arendt Nielsen; Karl G Henriksson
Journal:  Best Pract Res Clin Rheumatol       Date:  2007-06       Impact factor: 4.098

9.  Prevalence of fibromyalgia: a survey in five European countries.

Authors:  Jaime C Branco; Bernard Bannwarth; Inmaculada Failde; Jordi Abello Carbonell; Francis Blotman; Michael Spaeth; Fernando Saraiva; Francesca Nacci; Eric Thomas; Jean-Paul Caubère; Katell Le Lay; Charles Taieb; Marco Matucci-Cerinic
Journal:  Semin Arthritis Rheum       Date:  2009-02-27       Impact factor: 5.532

Review 10.  Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome.

Authors:  Dina Dadabhoy; Leslie J Crofford; Michael Spaeth; I Jon Russell; Daniel J Clauw
Journal:  Arthritis Res Ther       Date:  2008-08-08       Impact factor: 5.156

View more
  23 in total

1.  Performance of the American College of Rheumatology 2016 criteria for fibromyalgia in a referral care setting.

Authors:  Sakir Ahmed; Amita Aggarwal; Able Lawrence
Journal:  Rheumatol Int       Date:  2019-05-17       Impact factor: 2.631

2.  Chronic generalized pain disrupts whole brain functional connectivity in mice.

Authors:  Md Taufiq Nasseef; Weiya Ma; Jai Puneet Singh; Naoki Dozono; Kevin Lançon; Philippe Séguéla; Emmanuel Darcq; Hiroshi Ueda; Brigitte L Kieffer
Journal:  Brain Imaging Behav       Date:  2021-01-11       Impact factor: 3.978

Review 3.  The use and abuse of diagnostic/classification criteria.

Authors:  Rayford R June; Rohit Aggarwal
Journal:  Best Pract Res Clin Rheumatol       Date:  2015-05-23       Impact factor: 4.098

4.  [Screening and early diagnosis of psoriasis arthritis].

Authors:  P Härle
Journal:  Z Rheumatol       Date:  2013-10       Impact factor: 1.372

Review 5.  Fibromyalgia syndrome in need of effective treatments.

Authors:  Theoharis C Theoharides; Irene Tsilioni; Lauren Arbetman; Smaro Panagiotidou; Julia M Stewart; Rae M Gleason; Irwin J Russell
Journal:  J Pharmacol Exp Ther       Date:  2015-08-25       Impact factor: 4.030

Review 6.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

7.  Effects of 15 consecutive cryotherapy sessions on the clinical output of fibromyalgic patients.

Authors:  Lorenzo Bettoni; Felice Giulio Bonomi; Viviana Zani; Luigia Manisco; Annamaria Indelicato; Patrizia Lanteri; Giuseppe Banfi; Giovanni Lombardi
Journal:  Clin Rheumatol       Date:  2013-05-02       Impact factor: 2.980

8.  Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.

Authors:  Irene Tsilioni; Irwin J Russell; Julia M Stewart; Rae M Gleason; Theoharis C Theoharides
Journal:  J Pharmacol Exp Ther       Date:  2016-01-13       Impact factor: 4.030

9.  Fatigue in Women with Fibromyalgia: A Gene-Physical Activity Interaction Study.

Authors:  Fernando Estévez-López; Diego F Salazar-Tortosa; Daniel Camiletti-Moirón; Blanca Gavilán-Carrera; Virginia A Aparicio; Pedro Acosta-Manzano; Víctor Segura-Jiménez; Inmaculada C Álvarez-Gallardo; Ana Carbonell-Baeza; Diego Munguía-Izquierdo; Rinie Geenen; Eliana Lacerda; Manuel Delgado-Fernández; Luis J Martínez-González; Jonatan R Ruiz; María J Álvarez-Cubero
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

10.  Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment.

Authors:  Enrico Bellato; Eleonora Marini; Filippo Castoldi; Nicola Barbasetti; Lorenzo Mattei; Davide Edoardo Bonasia; Davide Blonna
Journal:  Pain Res Treat       Date:  2012-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.